SDEV
Stablecoin Development Corp.
$7.48
+3.82
(+104.37%)
Mkt Cap
377.36M
Volume
145,207,943
52W Range
0.8136-7.6493
Sector
Healthcare
Beta
0.09
EPS (TTM)
14.24 USD
P/E Ratio
0.53
Revenue (TTM)
4.67M USD
Rev Growth (5Y)
N/A
EPS Growth (5Y)
N/A
Company Description
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 10.46M | 14.40M | 10.20M | 9.93M | 6.60M | 12.51M | 18.23M | 11.90M | 4.38M | 1.05M |
| Net Income | (641.98M) | (7.22M) | (6.14M) | (10.61M) | (5.82M) | (11.04M) | (9.66M) | (6.54M) | (7.40M) | (13.15M) | (18.97M) | (15.19M) |
| EPS | -110.31 | -12.68 | -550.08 | -1767.93 | -920.46 | -1927.66 | -2968.11 | -2369.15 | -2940.00 | -8575.00 | -41772.00 | -47468.00 |
| Free Cash Flow | (8.43M) | (7.50M) | (4.28M) | (6.77M) | (9.24M) | (4.82M) | (8.19M) | (5.61M) | (6.51M) | (12.29M) | (18.68M) | (15.12M) |
| FCF / Share | -1.45 | -11.04 | -178.33 | -735.51 | -1297.40 | -841.77 | -2319.28 | -2031.86 | -2604.56 | -8004.56 | -41059.34 | -46675.93 |
| Operating CF | (8.43M) | (7.50M) | (4.26M) | (6.65M) | (9.19M) | (4.79M) | (8.18M) | (5.57M) | (6.27M) | (12.13M) | (18.56M) | (15.05M) |
| Total Assets | 10.65M | 45.91M | 50.42M | 16.40M | 23.98M | 48.24M | 11.22M | 9.36M | 10.08M | 15.38M | 5.08M | 7.54M |
| Total Debt | 776,000 | 1.67M | 2.61M | 2.04M | 551,000 | 503,000 | 4.05M | 0 | 0 | 0 | 1.66M | 0 |
| Cash & Equiv | 7.96M | 430,000 | 2.92M | 5.36M | 7.50M | 11.95M | 6.94M | 3.18M | 3.20M | 9.51M | 2.38M | 5.43M |
| Book Value | (22.83M) | (129,000) | 3.31M | 10.55M | 10.17M | 12.32M | 973,000 | 4.95M | 2.59M | 7.10M | (5.10M) | 1.85M |
| Return on Equity | N/A | N/A | -1.85 | -1.01 | -0.57 | -0.90 | -9.93 | -1.32 | -2.85 | -1.85 | N/A | -8.22 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.21M | 2.46M | (521,000) | 521,000 | 0 | 0 | 0 | 0 | 0 | 0 | 2.10M | 2.48M |
| Net Income | (41.07M) | 552.40M | (26.60M) | (1.29M) | (1.92M) | (3.53M) | (1.21M) | (1.21M) | (1.58M) | (3.21M) | (1.72M) | (1.35M) |
| EPS | -1.32 | 21.23 | -4.57 | -1.10 | -1.65 | -3.33 | -1.24 | -9.60 | -6.86 | -149.75 | -138.28 | -50.48 |
| Free Cash Flow | (5.96M) | (1.80M) | (2.27M) | (1.84M) | (2.99M) | (1.32M) | (1.56M) | (2.44M) | (1.51M) | (1.98M) | (431,000) | (647,000) |
| FCF / Share | -0.19 | -0.07 | -0.39 | -1.57 | -2.57 | -1.25 | -1.60 | -10.57 | -6.56 | -82.54 | -8.79 | -24.14 |
| Operating CF | (5.96M) | (1.80M) | (2.27M) | (1.84M) | (2.99M) | (1.32M) | (1.56M) | (2.44M) | (1.51M) | (1.98M) | (428,000) | (646,000) |
| Total Assets | 127.51M | 179.74M | 10.65M | 3.49M | 6.91M | 9.87M | 45.91M | 3.88M | 3.92M | 5.36M | 50.42M | 12.85M |
| Total Debt | 0 | 637,000 | 776,000 | 970,000 | 1.04M | 1.12M | 1.67M | 1.26M | 2.01M | 2.42M | 2.61M | 3.00M |
| Cash & Equiv | 6.97M | 18.41M | 7.96M | 2.31M | 5.48M | 8.60M | 430,000 | 776,000 | 751,000 | 1.82M | 2.92M | 3.47M |
| Book Value | 127.24M | 138.82M | (22.83M) | 1.63M | 4.25M | 6.17M | (129,000) | 1.07M | (617,000) | 160,000 | 3.31M | 7.04M |
| Return on Equity | -0.32 | 3.98 | N/A | -0.79 | -0.45 | -0.57 | N/A | -1.13 | N/A | -20.09 | -0.52 | -0.19 |
SDEV News
Stablecoin Development (NYSEAMERICAN:SDEV) Share Price Breaks Above Fifty Day Moving Average – Here’s What Happened
Stablecoin Development Stock Skyrockets Tuesday: What's Happening?
Stablecoin Development (NYSEAMERICAN:SDEV) Stock Price Passes Below 200 Day Moving Average – What’s Next?
SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly Novabay Pharmaceuticals, Inc.) Stockholders
Stablecoin Development Corporation Reports Second Quarter 2026 Financial Results
SDEV: Abbott Cooper PLLC Announces Investigation on Behalf of Stablecoin Development Corporation (Formerly NovaBay Pharmaceuticals, Inc.) Stockholders
Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Stablecoin Development (NYSEAMERICAN:SDEV) Share Price Crosses Below 50-Day Moving Average – Time to Sell?
Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update